Sarepta Therapeutics, Inc.
SRPT
$17.39
-$0.52-2.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.96M | -248.39M | 235.24M | 121.85M | 47.30M |
| Total Depreciation and Amortization | 41.08M | 38.96M | 37.72M | 38.64M | 39.76M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 289.98M | 331.05M | 237.86M | 228.93M | 196.43M |
| Change in Net Operating Assets | -573.86M | -668.77M | -716.61M | -741.90M | -679.99M |
| Cash from Operations | -300.75M | -547.15M | -205.79M | -352.49M | -396.50M |
| Capital Expenditure | -150.79M | -148.16M | -136.96M | -117.91M | -110.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 527.12M | 393.75M | 892.52M | 45.00M | -44.34M |
| Cash from Investing | 376.33M | 245.59M | 755.56M | -72.92M | -154.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.58M | -3.28M | -68.00K | -- | -- |
| Issuance of Common Stock | 34.65M | 73.07M | 79.53M | 77.76M | 79.41M |
| Repurchase of Common Stock | -25.01M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 45.35M | 45.35M | 45.35M | 0.00 | 0.00 |
| Cash from Financing | 51.40M | 115.14M | 124.81M | 77.76M | 79.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.98M | -186.42M | 674.58M | -347.65M | -471.75M |